Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:DRAD

Digirad (DRAD) Stock Price, News & Analysis

Digirad logo

About Digirad Stock (NASDAQ:DRAD)

Advanced Chart

Key Stats

Today's Range
$2.27
$2.38
50-Day Range
$2.79
$4.65
52-Week Range
$1.99
$8.84
Volume
11,339 shs
Average Volume
485,592 shs
Market Capitalization
$10.90 million
P/E Ratio
N/A
Dividend Yield
96.07%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Receive DRAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter.

DRAD Stock News Headlines

Henry Kissinger’s warning of Trump
In this video, you’ll also get nine other Trump-connected investments… All of which we believe could have as much as 10-fold potential over the next four years…but only for those who get in now before Trump enters the Oval Office and unleashes America’s full economic might.
Rock icon Jeff Beck dead at 78
See More Headlines

DRAD Stock Analysis - Frequently Asked Questions

Digirad Co. (NASDAQ:DRAD) released its quarterly earnings data on Wednesday, November, 18th. The medical equipment provider reported ($0.19) EPS for the quarter, missing the consensus estimate of $0.15 by $0.34. The medical equipment provider earned $30.35 million during the quarter. Digirad had a negative net margin of 5.32% and a negative trailing twelve-month return on equity of 3.75%.

Digirad shares reverse split on the morning of Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include AT&T (T), General Electric (GE), Gilead Sciences (GILD), Biocept (BIOC), Exelixis (EXEL), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
11/18/2020
Today
1/18/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:DRAD
Fax
N/A
Employees
618
Year Founded
N/A

Profitability

Net Income
$-4,630,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$114.18 million
Cash Flow
$3.32 per share
Book Value
$10.30 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.90 million
Optionable
Not Optionable
Beta
0.18
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:DRAD) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners